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ABSTRACT 
Objective: A hybrid imaging technique, Ultrasound Modulated Luminescence Tomography, that 
uses ultrasound to modulate diffusely propagating light has been shown to improve the spatial 
resolution of optical images. This paper is to investigate the underlying modulation mechanisms and 
the feasibility of applying this technique to improve the spatial resolution of bioluminescence 
tomography. Methods: Ultrasound Modulated Bioluminescence Tomography was studied 
numerically to identify the dominance of four factors (reduced optical scattering coefficient, optical 
absorption coefficient, refractive index, and luciferase concentration) on the depth of light 
modulation. In practice, an open source finite element method tool for simulation of diffusely 
propagating light, Near Infrared Fluorescence and Spectral Tomography, was modified to 
incorporate the effects of ultrasound modulation. The signal-to-noise ratios of detected modulated 
bioluminescent emissions are calculated using the optical and physical properties of a mouse model. 
Results: The modulation depth of the bioluminescent emission affected by the US induced variation 
of local concentration of the light emitting enzyme luciferase were at least two orders of magnitude 
greater than that caused by variations in the other factors. For surface radiances above 
approximately 107 photons/s/cm2/sr the corresponding SNRs are detectable with the current detector 
technologies. Conclusion: The dominant effect in generation of ultrasound modulated 
bioluminescence is ultrasound induced variation in luciferase concentration. The SNR analysis 
results confirm the feasibility of applying Ultrasound Modulated Bioluminescence Tomography in 
preclinical imaging of mice. Significance: The simulation model developed suggests ultrasound 
modulated bioluminescence tomography is a potential technique to improve the spatial resolution of 
bioluminescence tomography. 
Bioluminescence tomography is an optical molecular imaging method that can be used to assess the 
functional and pathological status of biological tissue in vivo. The achievable spatial resolution is 
severely limited by the dominance of optical scattering of the bioluminescent emission. A hybrid 
imaging technique, Ultrasound Modulated Optical Tomography (USMOT), that uses ultrasound to 
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modulate diffusely propagating light has been shown to improve the spatial resolution of optical 
images. Here the mechanisms of ultrasound modulation and the feasibility of applying USMOT to 
improve the spatial resolution of bioluminescence tomography are investigated. Ultrasound 
Modulated Bioluminescence Tomography (USMBLT) was studied numerically to identify the 
dominance of four factors (reduced optical scattering coefficient, optical absorption coefficient, 
refractive index, and luciferase concentration) on the depth of light modulation. In practice, an open 
source finite element method tool for simulation of diffusely propagating light, Near Infrared 
Fluorescence and Spectral Tomography (NIRFAST), was modified to incorporate the effects of 
ultrasound modulation. Simulation results show the modulation of the bioluminescent emission is 
significantly affected by the local concentration of the light emitting enzyme luciferase in 
comparison to the reduced scattering coefficient, absorption coefficient and refractive index. The 
feasibility of applying USMBLT in pre-clinical imaging was demonstrated by comparing the 
calculated signal-to-noise ratios of detected modulated bioluminescent emissions using the optical 
and physical properties of a mouse model with that of the limits of current detector technologies. 
Keywords: ultrasound modulated optical tomography, bioluminescence tomography, Finite Element 
Method, NIRFAST. 
1 INTRODUCTION 
Bioluminescence tomography (BLT) is based on the generation of visible light by a living organism 
resulting from an enzymatic reaction [1]. It is a sensitive technique that can be used to monitor 
cellular events in living tissues [2]. Advantageously BLT is characterised by extremely low 
background signals, short acquisition times (seconds to minutes) and high signal-to-noise ratios 
(SNRs) [3]. Moreover, due to its non-invasive nature and capability to enable longitudinal studies it 
is expected to have a significant impact on the implementation of strategies to reduce the number of 
animals used in pre-clinical imaging within the Principles of Humane Experimental Techniques. 
The achievable spatial resolution of images in BLT is, however, severely limited by the dominance 
of optical scattering in bioluminescent photon propagation in tissue. Strategies have been developed 
to help overcome the low resolution of BLT including the use of spectrally resolved BLT as a 
means to estimate the depth of an object based on the wavelength dependence of attenuation in 
tissue [4] and dual-modality molecular imaging techniques that co-register BLT images with those 
from other modalities such as magnetic resonance imaging (MRI) or positron emission tomography 
(PET) [2]. 
Alternative approaches to improve spatial resolution when diffuse light dominates are photo-
acoustic tomography (PAT) [5] and ultrasound modulated optical tomography (USMOT) [6]. These 
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are hybrid approaches which combine the advantages of ultrasonic and optical imaging techniques. 
In PAT, ultrasound (US) waves are excited by irradiating tissue with nanosecond scale pulses of 
light. Optical absorption by specific tissue chromophores (e.g. haemoglobin, melanin, flavins) 
produces a small temperature rise (less than 0.1 oC) that generates a broadband, low amplitude (less 
than 10 kPa) acoustic emission. Here image formation is based on the acoustic signals radiating 
from the surface of the sample, which are scattered much less in tissue than light. This approach, 
however, is not applicable to BLT as there is no pulsed light source present to generate acoustic 
waves. In USMOT, light illuminates the tissue and US is used to modulate its optical properties 
(absorption coefficient, reduced scattering coefficient and refractive index) at a rate corresponding 
to the US frequency which subsequently produces frequency modulated light. By spatially 
confining the US beam, images based on the optical properties of tissue localised within the US 
field can be obtained via detection of the modulated light. 
Conventionally temporally coherent light has been used in USMOT. Recently, however, ultrasound 
modulated fluorescence tomography (USMFT) [7-9] was performed which demonstrates the 
feasibility of USMOT with short coherence length light sources and hence its potential application 
in BLT. A current difficulty of USMOT using low coherence sources is the weak modulation of 
light it produces, quantified by measurement of the modulation depth which is defined as the ratio 
between modulated light intensity (AC signal) and unmodulated light intensity (DC signal) [10].  
The modulation depth for USMFT is of the order of 10-4 to 10-6 [11] as compared to 10-2 that is 
achieved using a laser source. In relation to imaging, the use of low coherent light sources produces 
modulated optical signals with low SNRs and image quality is limited by the capabilities of the 
signal detection device. 
Unlike fluorescence, bio- (or chemi-) luminescence does not require the use of excitation light to 
produce emission. In relation to imaging this eliminates the possibility of background signals being 
produced by the excitation light and any light generated by autofluorescence, and hence improves 
the achievable SNRs. This was recently demonstrated in a study that imaged a tissue phantom 
containing a chemi-luminescent material using Ultrasound Modulated Luminescence Tomography 
(USMLT) [12]. Here the SNR was found to be 80 and the image lateral resolution was 3 mm at a 
depth of 7 mm within a tissue phantom with a scattering coefficient of 30 cm-1. This represents a 3.5 
times improvement in spatial resolution compared to the conventional unmodulated optical 
tomography. More recently a method to reconstruct the density of a luminescent source in a highly 
scattering medium was presented based on the solution to a hybrid inverse source problem for the 
diffusion equation [13]. Using this approach the spatial resolution in reconstructed images was 
improved by a factor of 10 as compared to that in conventional BLT.  These studies provide support 
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to the hypothesis that US modulation techniques could be applied to improve the spatial resolution 
of BLT. Both the inverse problems of USMLT and BLT are to determine the source density 
distribution in the volume from boundary measurements of multiple scattered light based on 
radiative transport. Therefore it can be expected that the existing BLT reconstruction algorithms can 
be modified to be applied in the reconstruction of USMLT through coupling between US and light 
in terms of quantities that are changed by US pressure. Since the number of measurements can be 
dramatically increased by scanning US field and detecting US modulated luminescence signal, 
USMLT should be able to substantially help overcome the ill-posedness of the inverse problem.  
In the present study, the mechanisms of Ultrasound Modulated Bioluminescence Tomography 
(USMBLT) are first studied numerically to identify the dominance of four factors (reduced optical 
scattering coefficient, optical absorption coefficient, refractive index, and concentration of the 
bioluminescent target (luciferase)) on the strength of light modulation. In practice, an open source 
finite element method (FEM) tool for simulation of diffusely propagating light, Near Infrared 
Fluorescence and Spectral Tomography (NIRFAST), which simulates light propagation in 
biological tissue based on the finite element method (FEM), is modified to incorporate the effects of 
ultrasound modulation. The feasibility of applying USMBLT to imaging pre-clinical models is also 
investigated by calculating the SNR of USMBLT using the optical and physical properties of mice 
reported in the literature. Finally strategies to improve the SNR are discussed as well as the future 
prospects of USMBLT. 
2 METHODS 
2.1 Forward light modelling 
The fluence rate of the US modulated bioluminescence signal from a source located inside a tissue 
sample was calculated through modification of the open source model of light transport NIRFAST. 
In this case the fluence rate (W/mm2) of bioluminescent photons detected at the surface of a tissue 
sample can be calculated by calling the forward model in NIRFAST, which solves the following 
diffusion approximation of the radiative transport equation in the frequency domain [14], 
−𝛻 · 𝑘(𝑟)𝛻𝛷(𝑟, 𝑤) + (𝜇𝑎(𝑟) +
𝑖𝑤
𝑐𝑚(𝑟)
)𝛷(𝑟, 𝑤) = 𝑞0(𝑟, 𝑤),               (1) 
where 𝑘(𝑟) = 1/3(𝜇𝑎(𝑟) + 𝜇𝑠
′(𝑟)) is the diffusion coefficient, 𝜇𝑎(𝑟) is the absorption coefficient, 
𝜇𝑠
′(𝑟) is the reduced scattering coefficient, 𝛷(𝑟, 𝑤) is the photon fluence rate at the position r, w is 
the modulation frequency, 𝑐𝑚(𝑟) = 𝑐0/𝑛(𝑟) is the speed of light in the medium, 𝑐0 is the speed of 
light in vacuum, 𝑛(𝑟) is the refractive index, and 𝑞0(𝑟, 𝑤) is an isotropic source term. 
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To solve the diffusion approximation by FEM, a tetrahedral mesh for the volume of the tissue 
sample was generated containing an internal bioluminescence source and boundary data [15]. The 
mesh was comprised of a number of elements joined at vertex nodes. The optical properties of the 
sample were assigned to the mesh directly by using the Graphic User Interface (GUI) of NIRFAST. 
The simulations in this paper are based on equation (1).  
2.2 Ultrasound modulation of sample optical properties and luciferase concentration 
In order to investigate the underlying mechanisms of USMBLT the NIRFAST model was modified 
to account for the US induced temporal oscillation of the sample optical properties (reduced 
scattering coefficient, absorption coefficient, and refractive index). Changes in the bioluminescence 
intensity due to the oscillation of luciferase concentration were also taken into account. 
A starting point for establishing a framework to simulate USMBLT is consideration of the time 
dependent US field by defining the term US(t): 
𝑈𝑆(𝑡) = 𝐴𝑠𝑖𝑛(?⃗? · 𝑟 − 𝑤𝑡),                (2) 
where 𝐴 =
𝑃0
𝑤𝑢𝑠𝜌0𝑣𝑎
 [16] is the particle displacement amplitude, which is a function of the US 
pressure (𝑃0), the US angular frequency (wus), the mass density of the sample (𝜌0) and the acoustic 
velocity in the sample (𝑣𝑎). Of note is that 𝑃0 is the pressure at the fundamental frequency at the US 
focal zone. 
With reference to the literature [17] expressions for the US induced variation in sample optical 
parameters can be obtained:  
𝛥𝑛 = 𝑛0𝜂𝑘𝑈𝑆(𝑡),                                                (3a) 
𝛥𝜇𝑠
′ = 𝜇𝑠0
′[1 + 0.37𝜂]𝑘𝑈𝑆(𝑡),    (3b) 
𝛥𝜇𝑎 = 𝜇𝑎0𝑘𝑈𝑆(𝑡),                (3c) 
where 𝛥𝑛, 𝛥𝜇𝑠
′
 and 𝛥𝜇𝑎 are the changes in the refractive index, reduced scattering coefficient and 
absorption coefficient respectively. Here 𝑛0, 𝜇𝑠0
′, 𝜇𝑎0 are the corresponding equilibrium refractive 
index, reduced scattering coefficient, and absorption coefficient in the absence of US modulation. ?⃗?  
is the wave vector, 𝑘 =
2𝜋
𝜆𝑢𝑠
 is the relative scalar, 𝜆𝑢𝑠  is the US wavelength, and 𝑟  represents the 
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spatial position. 𝜂  is the elasto-optic coefficient which is related to the adiabatic piezooptical 
coefficient of the sample ∂𝑛/ ∂𝑝,  𝜌0 and 𝑣𝑎 such that 𝜂 = (∂𝑛/ ∂𝑝) 𝜌0𝑣𝑎
2 [18]. 
The next parameter for which the effects of US are considered is the bioluminescence intensity 
(photons/s/L) from the bioluminescence source. In the unmodulated case the bioluminescence 
intensity generated from an ATP/luciferin-luciferase solution can be expressed as [19]: 
𝑞0 = 𝑄𝑌𝑘𝑐𝑎𝑡𝐶0,                                            (4) 
where QY (photons/molecule) is the quantum yield of bioluminescence reactions and is defined as 
the efficiency of the production of a photon from a single reactant molecule. 𝑘𝑐𝑎𝑡 (𝑠
−1) is the 
catalytic constant, which represents the turnover number that indicates the maximum number of 
molecules of substrate that an enzyme can convert to product per catalytic site per second [19]. 𝐶0 is 
the concentration (molecule/L) of the enzyme at the site of interest in the tissue (active luciferase).  
The enzyme concentration under the interaction of an US field can be written as [20] 
𝐶1 = 𝐶0(1 + 𝛽𝑎
′𝑃(r, t)),                                      (5) 
where 𝛽𝑎
′ =
𝑘
𝜌0𝑣𝑎𝑤
·
1+?̂?−𝑖[?̂?+
2
3
?̂?2]
1+?̂?−𝑖[?̂?+
4
9
(𝜌+
1
2
)?̂?2]
+ 𝛽𝑎 , 𝜀̂ = √𝑤𝑎2/2𝛾, a is the radius of the enzyme molecule, 
𝛾 is fluid kinematic viscosity, 𝜌 =
𝜌𝑙
𝜌0
 , 𝜌𝑙 is the substrate density and can be obtained from the 
molecule radius and the molar mass, 𝛽𝑎 = 1/𝐾 is the compressibility of tissue, K=va
2ρ0 is the bulk 
modulus, and 𝑃(𝑟, 𝑡) is the acoustic pressure. Replacing C0 in eq.(6) with C1 in eq.(7), the 
bioluminescence intensity under the interaction of the US field is expressed as: 
𝑞 = 𝑄𝑌𝑘𝑐𝑎𝑡𝐶0(1 + 𝛽𝑎
′𝑃(𝑟, 𝑡)).                 (8) 
The relative variation of the bioluminescence intensity can then be expressed from eq. (8) and eq. (6) 
as: 
  
∆𝑞
𝑞0
=
|𝑞−𝑞0|
𝑞0
= 𝛽𝑎
′𝑃(𝑟, 𝑡).                          (10) 
3 SIMULATIONS 
3.1 Simulation methods 
The NIRFAST software tool was used to assign optical properties to nodes in the three dimensional 
(3D) mesh representing a tissue phantom. This assignment involved identification of nodes that lay 
inside a specified US field, as calculated using Eq.(2), by comparing the spatial co-ordinates of the 
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individual nodes to that of the US field. Eq. (3) was then used to calculate the temporal and spatial 
variation of the tissue optical properties in this field. Nodes outside the US field were assigned 
equilibrium properties of the tissue being modelled. It should be noted that the optical parameters in 
eq. (1) are time-independent. In this paper the temporal change of the optical properties are 
simulated by calculating the bioluminescence fluence rates separately at 24 phases within a period 
and then connecting all these fluence rates in sequence (as shown later in Fig. 6.).  
The spatial co-ordinates of the bioluminescence source were next specified. In practice, the region 
of the bioluminescence source was divided into several layers along the direction of US propagation, 
each with an allocated pressure. The bioluminescence intensity by each layer was then determined 
using Eq. (6). Finally the modulation depth was calculated using: 
𝑚 =
|𝐹𝑈𝑆−𝐹|
𝐹
,                                                              (6) 
While 𝐹𝑈𝑆 and F are the bioluminescence fluence rates detected at the surface in the presence and 
absence of US respectively.  
3.2 SNR analysis of in vivo detection 
Calculations were carried out to predict the SNR that could be achieved in the in vivo application of 
USMBLT. These calculations were based on use of parameters relating to realistic experimental 
configurations. Here the detection system was considered to consist of a PMT, transimpedance 
amplifier and lock-in amplifier (LIA). The SNR for such a system can be expressed as: 
SNR =
𝑃𝑚
𝑃𝑛
,                                           (7) 
where 𝑃𝑚  is the power of the detected modulated signal, 𝑃𝑛 = 𝑃𝑛𝑠 + 𝑃𝑑𝑐 + 𝑃𝑎  is the total noise 
power, with 𝑃𝑛𝑠, 𝑃𝑑𝑐 and 𝑃𝑎 relating to the noise arising from the bioluminescence light (modulated 
signal and unmodulated signal), dark current and ambient light level respectively.  
Calculation of the SNR also requires knowledge of the output voltage of the transimpedance 
amplifier. The output relating to the expression of bioluminescence modulated by US with a 
frequency of 𝑓𝑈𝑆 is: 
𝑣𝐴𝐶 = 𝑉𝐴𝐶 sin(2𝜋𝑓𝑈𝑆𝑡)                                 (8) 
𝑉𝐴𝐶 = 2𝜋𝑆𝐿𝐴𝐶ℎ𝑓𝐸𝐴𝑛𝑜𝑅𝑀,                      (9) 
where S is the effective area of the PMT, 𝐿𝐴𝐶  (photons/s/cm
2/sr)  is the modulated surface 
radiance, h is Planck's constant, f = c/λ is the light frequency, and λ is the light wavelength. EAno is 
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the anode radiance sensitivity of the PMT in the bioluminescence wavelength, 𝑅 and 𝑀 are the 
input impedance and gain of the transimpedance amplifier respectively. 
Thus the power of the optical modulated signal can be expressed by:  
𝑃𝑚 =
𝑉𝐴𝐶
2
2
.                                                        (10) 
For a PMT, the current measured at the anode is the result of the multiplication of electrons emitted 
at the cathode, the number of which follows a Poisson random process. Here the mean number of 
electrons (?̅?) detected was considered, with N being the number of electrons at the cathode within a 
time period of ∆𝑡:  
?̅? =
𝐼𝐶𝑎𝑡ℎ∆𝑡
𝑒
,                                       (11) 
where: 
𝐼𝐶𝑎𝑡ℎ = 2𝜋𝑆(𝐿𝐴𝐶 + 𝐿𝐷𝐶)ℎ𝑓𝐸𝐶𝑎𝑡ℎ    (12) 
is the cathode current, 𝑒 is the electron charge, 𝐿𝐷𝐶  is the unmodulated surface radiance, 𝐿𝐴𝐶 =
𝑚𝐿𝐷𝐶, m is the modulation depth, and 𝐸𝐶𝑎𝑡ℎ is the cathode radiance sensitivity. 
The shot noise X can be expressed as: 
𝑋 = 𝑁 − ?̅?,                   (13) 
the noise current at the anode is: 
𝐼𝐴𝑛𝑜 =
𝑋𝑒𝐺
∆𝑡
,                 (14) 
where G is the PMT gain. The noise related to the voltage output from the transimpedance amplifier 
is: 
𝑉 = 𝐼𝐴𝑛𝑜𝑅𝑀.                        (15) 
Thus the variance of the noise voltage is: 
𝜎𝑉
2 = (
𝑒𝐺𝑅𝑀
∆𝑡
)2𝜎𝑋
2,               (16) 
where 𝜎𝑋
2 = 𝜎𝑁
2 = ?̅? according to the property of Poisson process. 
Following Parseval's theory the total noise power equals twice the variance of the noise voltage, 
thus the output noise power due to signal is: 
𝑃𝑛𝑠 = 2𝜎𝑉
2.                                          (17) 
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The calculations are based on the assumption that a lock-in amplifier is used in detection. If it is 
supposed for a time window of ∆𝑡 the bandwidth of the lock-in amplifier is given by 𝐵 =
1
2∆𝑡
, the 
bandwidth of the system is B as well. The output noise power due to signal can thus be expressed as: 
𝑃𝑛𝑠 = (2√𝑒𝐼𝐶𝑎𝑡ℎ𝐵𝐺𝑅𝑀)
2.                                      (18) 
3.3 Simulated experiment 
The simulation experiment was based on a simplified version of an experimental system used in 
previous studies of USMLT performed in our laboratory using a chemi-luminescent source [12]. 
Here, the tissue phantom was modelled as a rectangular slab (55 mm × 55 mm × 15 mm) containing 
a cylindrical bioluminescent source (1 mm diameter, 5 mm height) in the centre of the slab (see 
Figure 1). The detection system was modelled as a PMT and aperture which were approximated as 
a circular disk detector (8 mm) located on the surface of the tissue phantom. The mesh generation 
tool in NIRFAST was then used to discretise the tissue phantom slab and cylindrical bioluminescent 
source into tetrahedral elements with average edge lengths of 0.2 mm and 0.3 mm using the 
Delaunay Triangulation method. The circular detector was discretised into triangles of average edge 
length of 0.2 mm using the same tool. These element sizes were chosen as they are sufﬁciently 
small to confer numerical stability and accuracy to the diffusion computations without being 
computationally expensive. The vertices of the Delaunay Triangulation were used as point sources 
and point detectors forming the source and detector respectively. 
The US field was considered to be generated by a focussed US transducer with the focal zone being 
approximated as a thin cylinder (2 mm diameter, 18 mm long). Only the US field in this focal zone 
was considered in the simulation where it was assumed to propagate without attenuation in a linear 
manner as a plane wave with stratified pressure amplitude variation along the long axis of the 
cylinder. 
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Figure 1 Simulated experimental setup based on a simplified version of the system used in [12] with 
the tissue phantom being was modelled as a rectangular slab (55 mm × 55 mm × 15 mm) containing 
a cylindrical bioluminescent source (1 mm diameter, 5 mm height) at a depth of z = 0.5 mm. The 
US focal zone (green) was simplified as a 2 mm diameter, 18 mm long cylinder and the detector 
(blue) as a disk located at z = 7.5 mm.  
The parameters used in simulations were based on literature values of the optical and physical 
properties observed in biological tissue [21] and luciferase [19] as listed in Table 1.  
 
adiabatic piezooptical 
coefficient  𝜕𝑛/𝜕𝑝 [18] 
1.466 × 10−10 m2N−1 quantum yield 𝑄𝑌 [19] 
0.48 photons per 
molecule 
medium acoustic velocity 𝑣𝑎 1500 m 𝑠
−1 catalytic constant 𝑘𝑐𝑎𝑡 [19] 3 × 10
−2 s−1 
medium density 𝜌0 1000 kg m
−3 
𝐶𝑚 (𝐶0 =
𝐶𝑚𝑁𝐴
𝑘𝐷𝑎
)  [22] 20 mg ml−1 
equilibrium refractive index 𝑛0 1.4 
compressibility of medium  
𝛽𝑎 
4.44 × 10−10 Pa−1 
equilibrium reduced scattering 
coefficient 𝜇𝑠0
′ 
1 mm−1 
molar mass of luciferase 
kDa [23] 
62 kg mol-1 
equilibrium  absorption 
coefficient 𝜇𝑎0 
0.02 mm−1 radius of luciferase 3 nm 
fluid kinematic viscosity γ  10-6  m2s-1 temperature 293 K 
Table 1 Parameters used to simulate the tissue phantom and bioluminescence source, values taken 
from the literature.  
Calculation of the SNR in the simulated experiment were based on the parameters of 
instrumentation used in previous experimental studies [12]. Table 2 shows values taken from the 
datasheets of a Hamamatsu H5783-20 PMT and Stanford Instruments SR445A transimpedance 
amplifier. The simulated radiance emitted at the surface of the mouse was based on literature values 
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from BLT which was found to lie in the range of 106  photons s-1 cm-2 sr-1 to 1011 photons s-1 cm-2 sr-1 
[24, 25]. 
PMT anode radiance sensitivity EAno 3.9×104 A W-1 
PMT cathode radiance sensitivity Ecath 78 mA W
-1 
PMT gain G 4×105 
input impedance  of transimpedance amplifier R 500 Ω 
gain of transimpedance amplifier M 5 
light wavelength λ 650 nm 
lock-in bandwidth B 0.1 Hz 
Table 2 Parameters used in SNR calculations based on instrument datasheet and literature 
values of bioluminescent sources. 
4 RESULTS AND DISCUSSION 
4.1 Ultrasound modulation of sample optical properties and luciferase concentration 
The US induced changes in the reduced optical scattering coefficient, optical absorption coefficient, 
refractive index, and luciferase concentration dependent bioluminescence emission intensity relative 
to their equilibrium values were investigated as a function of US pressure using eq. (3) and eq. (7).  
The applied US field is obtained using eq. (2) and it is over a medically relevant pressure range up 
to 10 MPa and with an arbitrary frequency of 1 MHz. Figure 2 shows these relative changes of 
𝛥𝜇𝑠
′/𝜇𝑠0
′, 𝛥𝜇𝑎/𝜇𝑎0, 𝛥𝑛/𝑛0 and 𝛥𝑞/𝑞0. Results are shown for the pressure maximum in the US 
cycle which is frequency independent. Over the pressure range considered, a linear increase in the 
parameter change is seen with pressure. This relationship is clear from inspection of eq. (3) which 
describes the optical properties of the tissue phantom. The absolute value and rate of change for 
𝛥𝑛/𝑛0 was the lowest of these parameters which corresponds to the smallest constant in eq. (3a). 
The change in 𝛥𝑞/𝑞0 with pressure from eq. (7) is predicted to be proportional to the applied US 
pressure as well and it undergoes the greatest change. 
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Figure 2 Effect of US pressure (f = 1 MHz) on the relative change in the reduced optical scattering 
coefficient, optical absorption coefficient, refractive index, and concentration of the bioluminescent 
target, denoted as 𝜟𝝁𝒔
′/𝝁𝒔𝟎
′, 𝜟𝝁𝒂/𝝁𝒂𝟎, 𝜟𝒏/𝒏𝟎 and 𝜟𝒒/𝒒𝟎respectively.  
The corresponding changes in modulation depth of the detected signal arising individually from 
𝛥𝜇𝑠
′/𝜇𝑠0
′, 𝛥𝜇𝑎/𝜇𝑎0, 𝛥𝑛/𝑛0 and 𝛥𝑞/𝑞0 over the 0 MPa to 10 MPa pressure range studied in Figure 
2 were also calculated. Figure 3 shows the parameter with the greatest effect on modulation depth is 
the change in the bioluminescence emission intensity. Figure 3 also shows a linear increase in the 
modulation depth with US pressure for all four parameters studied. This linear relationship between 
modulation depth and US pressure is in agreement with the analytic solution obtained by Yuan et al 
[20] and the recent experimental results from Jarrett [26] that demonstrated this for the case of a 
fluorescent source and an LED source respectively. Although all parameters studied show a linear 
trend with pressure, their absolute values and rates of change vary considerably. In fact the 
bioluminescence intensity due to the US induced change of luciferase concentration (Figure 3 (d)) is 
approximately two orders of magnitude greater than that caused by changes in the reduced 
scattering coefficient (Figure 3 (a)) and absorption coefficient (Figure 3 (b)) and of the order of 105 
times higher than that related to changes in the refractive index (Figure 3 (c)). A modulation depth 
of 3.6×10-4 (AC/DC = 3.6 μV/10 mV) was obtained from our previous chemi-luminescence 
experimental result at a phantom with μs = 0.21 mm-1 and  μa = 0.00005 mm-1 [3]. The US 
frequency and peak pressure used were 1 MHZ and 0.42 MPa respectively. Here in this paper the 
modulation depth at the same frequency, pressure and optical properties was calculated to be 
2.1×10-4 , which is quite close to the previously measured value. The difference of the significand 
might be due to the measurements errors and simulation assumptions (e.g. perfect focused US). Of 
note also is the modulation depth magnitude for the case of bioluminescence is comparable to 
experimental [4] and theoretically predicted results [5] for fluorescence.  
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Figure 3 Change in modulation depth arising individually from 𝜟𝝁𝒔
′
 (a), 𝜟𝝁𝒂 (b),    𝜟𝒏 (c) and 𝜟𝒒 
(d) with respect to maximum US pressure.  
Figure 4 Normalised USMBL signal (a) and modulation depth (b) as a function of luciferase 
concentration. 
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The dominance of luciferase concentration dependent changes in bioluminescence intensity on the 
modulation depth were further investigated by studying the affect luciferase concentration has on 
the ultrasound modulated signal and modulation depth over a biologically relevant concentration 
range of 10 mg ml-1 to 100 mg ml-1. Figure 4 shows the results of these calculations. Here the 
normalised ultrasound modulated signal is shown to investigate the trend with concentration which 
was found to vary with the concentration linearly. This linear relationship of modulated signal with 
source concentration is consistent with the expression (18) derived in [27]. It should also be noted 
that in [28] the US modulated fluorescence signal was observed to only increase when the 
fluorophore concentration is low and it will decrease in the high concentration region. This is due to 
the ‘inner filter effect’, in which the excitation light is mostly absorbed by the fluorescent molecules 
near the light input region, and the fluorescence emission is reabsorbed by the fluorophores along 
the light transmission path in an optically dense solution [29]. However, the process of generating 
bioluminescence does not require excitation light for light emission thus no ‘inner filter effect’ 
exists for USMBLT. This is an advantage of USMBLT when the USMBL signal is used to quantify 
the luciferase concentration because the relationship is much simpler. The modulation depth is 
invariant with luciferase concentration as shown in Figure 4 (b) because the modulated 
bioluminescence signal and unmodulated signal have the same trend with luciferase concentration. 
The spatial variation of US induced changes in 𝜟𝒒/𝒒𝟎 and the corresponding modulation depths 
detected as US propagates through the focal zone were studied. These variations are a result of the 
sinusoidal nature of the modelled US wave which produces a spatial and temporal variation in 
pressure along the focal zone, both of which are a function of the applied US frequency. Figure 5 
shows the variation in 𝜟𝒒/𝒒𝟎 caused by a 0.75 MHz, 1 MPa ultrasound wave along the length of 
the bioluminescence source (x direction) over a time frame corresponding to one period of wave 
oscillation. 
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Figure 5 Oscillation of 𝜟𝒒/𝒒𝟎 over one US period at a frequency of 0.75 MHz. The relative phase 
of the US is labelled on the x axis. 
The observed spatial variation in 𝜟𝒒/𝒒𝟎 as the sound propagates is a result of the changing US 
pressure distribution and affects the modulation depth of the detected signal.  The modulation depth 
for US frequencies of 0.75 MHz, 1.5 MHz and 2.25 MHz was also calculated. The pressure 
distributions set up by each frequency will vary as a result of their differing wavelengths and their 
size relative to that of the bioluminescence source. Here the 1 mm diameter source simulated 
corresponds to distances equal to λ/2, λ, 3λ /2 respectively of the three frequencies studied. The 
resulting variation in modulation depth for these three conditions was calculated and is shown in 
Figure 6. It should be noted that Figure 6 includes US induced changes in the reduced optical 
scattering coefficient, optical absorption coefficient and refractive index but these are dominated by 
changes in concentration. 
Figure 6 Oscillation of modulation depth of the detected signal over one US period for frequencies 
of 0.75 MHz (a), 1.5 MHz (b) and 2.25 MHz (c).  
The modulation depth is shown in Figure 6 (a) to be a maximum when the phase is 0, at which time 
the relative change of source intensity is even symmetrical, as shown in Figure 5 (a). The oscillation 
of the modulation depth is due to the summation of USMBL signals originating from each layer of 
the source region along the US transmission direction at the detector. When the US pressure 
distribution is even symmetrical to the centre axis of the cylindrical source, the USMBL signals 
from two symmetrical layers of the source are in phase and sum constructively at the detector so the 
modulation depth is the highest.  When the US pressure distribution is odd symmetrical to the 
centre axis, the USMBL signals from the two symmetrical layers of the source are out of phase and 
sum destructively at the detector so the modulation depth is the lowest. It should be noted that when 
the phase sum or absolute difference is π, the modulation depths are the same. This is because the 
pressure distributions within the source region at these conditions are either odd symmetrical or 
even symmetrical with each other (e.g. (b) and (d)) in Figure 5. Since modulation depth is an 
absolute value, its frequency is twice that of the US. A similar trend is observed in Figures 6 (b) and 
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(c) with the modulation depth varying at twice the US frequency. Interestingly the maximum 
modulation depth is found to decrease with increase in frequency over the range studied. It is 
thought that this observation is related to the size of the bioluminescence source and the ultrasound 
frequency as has been observed in studies of ultrasound modulated fluorescence tomography [8]. 
It should be noted that these findings are based on simulations of a simplified experimental situation 
in which the tissue phantom is considered to be homogenous, unlike the case of real biological 
tissue. In addition, US propagation to the focal zone is not modelled and only the pressure at the 
fundamental frequency is considered in this paper. It is assumed that there is no attenuation within 
the focal zone. These assumptions will result in the modelled US field distribution differing from 
the experimental situation on account of US non-linear propagation, absorption, scattering, and 
beam divergence. All the speed related parameters in section 2 would also become functions of 
position and time instead of constants. However, the magnitude of the calculated modulation depth 
should still be the same because the fundamental component of US would always dominant. 
Nevertheless, further work will involve incorporation of these effects into the NIRFAST software 
tool through the use of an acoustic toolbox such as k-Wave [30] to model pressure distribution more 
realistically.  
4.2 SNR analysis of in vivo detection 
The effect of PMT diameter, surface radiance of bioluminescence and modulation depth on the 
SNR of USMBLT system were analysed based on the method described in section 2. Figure 7 
shows the SNR calculated for six different surface radiances (106, 107, 108, 109, 1010, and 1011 
photons s-1 cm-2 sr-1) as a function of PMT diameter with an RMS modulation depth of 9.6 × 10−4 
(Figure 7 (a)) and as a function of modulation depth for a fixed PMT diameter of 8 mm (Figure 7 
(b)). The contribution of the ambient light and the dark current to the noise power were estimated 
based on a noise voltage level of 0.4 μVrms, as detected in a previous experiment [12].                                  
2 4 6 8 10
x 10
-4
-40
-20
0
20
40
60
80
100
Modulation Depth
S
N
R
(d
B
)
 
 
radiance=10
11
radiance=10
10
radiance=10
9
radiance=10
8
radiance=10
7
radiance=10
6
10 15 20 25
-10
0
10
20
30
40
50
60
70
80
90
100
Diameter of PMT(mm)
S
N
R
(d
B
)
 
 
radiance=10
11
radiance=10
10
radiance=10
9
radiance=10
8
radiance=10
7
radiance=10
6
                     (a)                                                                       (b) 
17 
 
Figure 7 SNR simulation for USMBLT experiments for different surface radiance as a function of 
PMT diameter, modulation depth = 9.6 × 10−4 (a); and as a function of modulation depth, PMT 
diameter = 8 mm (b). 
The feasibility of applying USMBLT to pre-clinical imaging is contingent on detection of 
modulated optical signals within the noise limits of current detector technologies. Results in Figure 
7 are based on calculations for a mouse model with detector capabilities matching that of a PMT 
used in previous experimental studies (Hamamatsu H5783-20).  Inspection of Figure 7 (a) shows 
SNRs achieved with radiances ranging from 106 photons s-1 cm-2 sr-1 to 107 photons s-1 cm-2 sr-1 fall 
below the noise level of the simulated detector. However, for radiances above 107 photons s-1 cm-2 
sr-1 the SNRs are comfortably detectable within the limits of the detector modelled in [12]. Apart 
from changing the radiance, the SNR can also be improved by increasing the PMT diameter as seen 
in Figure 7 (a) and the modulation depth as shown in Figure 7 (b). It is noted that the nonlinear 
relationship of SNR with respect to radiance was caused by the 0.4 μVrms noise voltage level from 
dark current and ambient light.  
Overall there are good prospects for the application of USMBLT in pre-clinical imaging. Besides, 
considerable effort has been directed to establish novel luciferases that can exert a brighter, stable, 
and red-shifted bioluminescence by mutation [31, 32], DNA optimization [33] or bioluminescence 
resonance energy transfer with ﬂuorescent proteins [34]. A novel luciferase NLuc has also been 
established that can emit approximately 100-fold brighter and more stable bioluminescence than the 
gene firefly luciferase (Fluc) studied here [35]. Such signal improvement will lead to greater SNRs 
and enhance the quality of USMBLT images. Other strategies to improve the modulated optical 
signal relate to the use of ultrasound microbubble contrast agents that have high compressibility and 
as such have the capability to increase the change in the bioluminescent source intensity as 
indicated by eq. (7) [7]. 
5 CONCLUSION 
In this work numerical simulations were carried out to investigate the mechanisms dominant in 
generation of USMBL signals using the NIRFAST software tool. Simulations were based on the 
optical and physical properties of a mouse model and detection capabilities of instrumentation used 
in previous experimental work. Results demonstrate that the dominant effect in generation of 
USMBL is ultrasound induced variation in luciferase concentration. This effect was determined to 
be approximately two orders of magnitude greater than that caused by changes in the reduced 
scattering coefficient and absorption coefficient and of the order of 105  times higher than that 
related to changes in the refractive index. These findings make it clear that to improve the 
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compressibility of the luciferase-luciferin solution and thus the variation of its concentration with 
US is the major way to improve the modulation depth. 
The effect of US frequency on modulation depth was also studied. Depending on the distribution of 
the sinusoidal pressure along the US transmission direction, the USMBL signals can sum either 
constructively or destructively at the detector, which results in an oscillation of the modulation 
depth over time. The results here predict the modulation depth varies at twice the US frequency and 
its absolute value is a function of the US wavelength relative to the bioluminescence source size. 
The SNR analysis results confirm the feasibility of applying USMBLT in preclinical imaging of 
mice to improve the spatial resolution of BLI. It was determined that for surface radiances above 
approximately 107 photons s-1 cm-2 sr-1 the corresponding SNRs are detectable with devices 
currently used in [12]. The development of novel luciferases that can exert bioluminescence above 
such radiance level will also make the application highly potential. The measured USMBL signal 
can provide valuable data for BLI reconstruction to make the reverse problem less ill-conditioned. 
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